Brief: Orchestra Biomed Reports First Quarter 2023 Financial Results And Provides Business Update
Orchestra Biomed Holdings Inc OBIO.O :
* ORCHESTRA BIOMED REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
* ORCHESTRA BIOMED HOLDINGS INC Q1 REVENUE $1.2 MILLION
* ORCHESTRA BIOMED HOLDINGS INC - ANTICIPATES THAT CASH &
CASH
EQUIVALENTS, MARKETABLE SECURITIES ARE SUFFICIENT TO FUND
OPERATIONS INTO 2026
* ORCHESTRA BIOMED HOLDINGS INC- QTRLY LOSS PER SHARE $0.40
Source text for Eikon: ID:nGNX7LmRf0
Further company coverage: OBIO.O
Recent news on Orchestra Biomed Holdings
See all newsBrief: Orchestra Biomed Announces Pricing Of Public Offering
Orchestra BioMed slides after starting equity offering
Brief: Orchestra Biomed Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Orchestra Biomed Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Orchestra BioMed Q2 revenue drops, net loss widens